INDO US BIO-TECH | KOTYARK INDUSTRIES | INDO US BIO-TECH/ KOTYARK INDUSTRIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.6 | - | - | View Chart |
P/BV | x | 8.0 | 7.5 | 106.0% | View Chart |
Dividend Yield | % | 0.0 | 0.7 | - |
INDO US BIO-TECH KOTYARK INDUSTRIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-24 |
KOTYARK INDUSTRIES Mar-24 |
INDO US BIO-TECH/ KOTYARK INDUSTRIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 304 | 1,424 | 21.3% | |
Low | Rs | 90 | 535 | 16.8% | |
Sales per share (Unadj.) | Rs | 36.3 | 263.6 | 13.8% | |
Earnings per share (Unadj.) | Rs | 4.1 | 21.6 | 19.1% | |
Cash flow per share (Unadj.) | Rs | 4.5 | 29.6 | 15.2% | |
Dividends per share (Unadj.) | Rs | 0 | 7.50 | 0.0% | |
Avg Dividend yield | % | 0 | 0.8 | 0.0% | |
Book value per share (Unadj.) | Rs | 31.3 | 140.2 | 22.3% | |
Shares outstanding (eoy) | m | 20.05 | 10.28 | 195.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 5.4 | 3.7 | 146.0% | |
Avg P/E ratio | x | 47.9 | 45.4 | 105.6% | |
P/CF ratio (eoy) | x | 43.6 | 33.1 | 132.0% | |
Price / Book Value ratio | x | 6.3 | 7.0 | 90.1% | |
Dividend payout | % | 0 | 34.7 | 0.0% | |
Avg Mkt Cap | Rs m | 3,951 | 10,069 | 39.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 9 | 23 | 39.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 728 | 2,710 | 26.9% | |
Other income | Rs m | 3 | 9 | 34.5% | |
Total revenues | Rs m | 732 | 2,719 | 26.9% | |
Gross profit | Rs m | 108 | 445 | 24.3% | |
Depreciation | Rs m | 8 | 83 | 9.7% | |
Interest | Rs m | 15 | 66 | 23.2% | |
Profit before tax | Rs m | 88 | 306 | 28.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 6 | 84 | 6.6% | |
Profit after tax | Rs m | 83 | 222 | 37.2% | |
Gross profit margin | % | 14.8 | 16.4 | 90.4% | |
Effective tax rate | % | 6.3 | 27.5 | 22.9% | |
Net profit margin | % | 11.3 | 8.2 | 138.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 731 | 1,372 | 53.3% | |
Current liabilities | Rs m | 175 | 460 | 38.0% | |
Net working cap to sales | % | 76.4 | 33.6 | 227.0% | |
Current ratio | x | 4.2 | 3.0 | 140.4% | |
Inventory Days | Days | 1 | 4 | 29.5% | |
Debtors Days | Days | 95,439,526 | 464 | 20,576,086.9% | |
Net fixed assets | Rs m | 107 | 845 | 12.7% | |
Share capital | Rs m | 201 | 103 | 195.1% | |
"Free" reserves | Rs m | 427 | 1,338 | 31.9% | |
Net worth | Rs m | 627 | 1,441 | 43.5% | |
Long term debt | Rs m | 28 | 305 | 9.2% | |
Total assets | Rs m | 838 | 2,217 | 37.8% | |
Interest coverage | x | 6.8 | 5.7 | 119.8% | |
Debt to equity ratio | x | 0 | 0.2 | 21.1% | |
Sales to assets ratio | x | 0.9 | 1.2 | 71.1% | |
Return on assets | % | 11.7 | 13.0 | 89.9% | |
Return on equity | % | 13.2 | 15.4 | 85.4% | |
Return on capital | % | 15.7 | 21.3 | 74.0% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -46 | -156 | 29.5% | |
From Investments | Rs m | 43 | -534 | -8.0% | |
From Financial Activity | Rs m | 12 | 738 | 1.6% | |
Net Cashflow | Rs m | 9 | 48 | 18.8% |
Indian Promoters | % | 70.2 | 67.7 | 103.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 1.5 | - | |
FIIs | % | 0.0 | 0.9 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 32.4 | 92.2% | |
Shareholders | 973 | 5,617 | 17.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | KOTYARK INDUSTRIES |
---|---|---|
1-Day | -1.42% | -3.10% |
1-Month | -0.82% | 0.55% |
1-Year | 34.47% | 35.07% |
3-Year CAGR | 79.07% | 20.83% |
5-Year CAGR | 54.26% | 12.02% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the KOTYARK INDUSTRIES share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of KOTYARK INDUSTRIES the stake stands at 67.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of KOTYARK INDUSTRIES.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
KOTYARK INDUSTRIES paid Rs 7.5, and its dividend payout ratio stood at 34.7%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of KOTYARK INDUSTRIES.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.